Loading...
Loading...
India's trastuzumab imports from UNITED STATES total $3.3M across 43 shipments from 15 foreign suppliers. F. HOFFMANN -LA ROCHE LTD., leads with $1.9M in import value; the top 5 suppliers together control 96.9% of this origin. Leading Indian buyers include ROCHE PRODUCTS (INDIA) PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for trastuzumab โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

F. HOFFMANN -LA ROCHE LTD., is the leading Trastuzumab supplier from UNITED STATES to India, with import value of $1.9M across 3 shipments. The top 5 suppliers โ F. HOFFMANN -LA ROCHE LTD.,, ADIRAMEDICA LLC, F HOFFMANN -LA ROCHE LTD, F. HOFFMANN -LA ROCHE LIMITED, F HOFFMANN -LA ROCHE LIMITED โ collectively account for 96.9% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | F. HOFFMANN -LA ROCHE LTD., | $1.9M | 3 | 56.9% |
| 2 | ADIRAMEDICA LLC | $523.2K | 2 | 15.8% |
| 3 | F HOFFMANN -LA ROCHE LTD | $335.0K | 1 | 10.1% |
| 4 | F. HOFFMANN -LA ROCHE LIMITED | $308.0K | 1 | 9.3% |
| 5 | F HOFFMANN -LA ROCHE LIMITED | $161.8K | 1 | 4.9% |
| 6 | NEWLIFE MEDICALS USA INC | $31.0K | 1 | 0.9% |
| 7 | CELTIS HEALTHCARE LLC | $18.3K | 3 | 0.6% |
| 8 | Espee Biopharma & Finechem LLC | $16.1K | 1 | 0.5% |
| 9 | ESPEE BIOPHARMA & FINECHEM LLC | $11.7K | 1 | 0.4% |
| 10 | KREATIVE TECHNOLABS | $7.2K | 6 | 0.2% |
| 11 | NEW LIFE MEDICALS (USA) INC. | $5.4K | 1 | 0.2% |
| 12 | R & D SYSTEMS, INC. | $3.7K | 3 | 0.1% |
| 13 | R D SYSTEMS INC | $3.6K | 4 | 0.1% |
| 14 | R&D SYSTEMS INC | $2.2K | 4 | 0.1% |
| 15 | PIERCE BIOTECHNOLOGY INC | $1.0K | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ROCHE PRODUCTS (INDIA) PRIVATE LIMITED | $2.2M | 5 | 66.2% |
| 2 | INTAS PHARMACEUTICALS LIMITED | $537.7K | 3 | 16.2% |
| 3 | ROCHE PRODUCTS I PVT LTD | $335.0K | 1 | 10.1% |
| 4 | ROCHE PRODUCTS I PRIVATE LIMITED | $161.8K | 1 | 4.9% |
| 5 | INTAS PHARMACEUTICALS LTD | $31.0K | 1 | 0.9% |
| 6 | ZYDUS LIFESCIENCES LIMITED | $14.1K | 3 | 0.4% |
| 7 | INTAS PHARMACEUTICALS LTD. | $13.3K | 1 | 0.4% |
| 8 | CURATEQ BIOLOGICS PRIVATE LIMITED | $9.5K | 1 | 0.3% |
| 9 | AGILE DIAGNOSTICS | $7.1K | 7 | 0.2% |
| 10 | KRISHGEN BIOSYSTEMS | $6.0K | 4 | 0.2% |
| 11 | BI BIOTECH INDIA PRIVATE LIMITED | $2.2K | 4 | 0.1% |
| 12 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $1.4K | 4 | 0.0% |
| 13 | KRISHGEN BIOSYSTEMS PRIVATE LIMITED | $1.3K | 2 | 0.0% |
| 14 | BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED | $739 | 4 | 0.0% |
| 15 | AIC ENTERPRISES PRIVATE LIMITED | $577 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Trastuzumab suppliers from UNITED STATES to India include F. HOFFMANN -LA ROCHE LTD.,, ADIRAMEDICA LLC, F HOFFMANN -LA ROCHE LTD. The leading supplier is F. HOFFMANN -LA ROCHE LTD., with import value of $1.9M USD across 3 shipments. India imported Trastuzumab worth $3.3M USD from UNITED STATES in total across 43 shipments.
India imported Trastuzumab worth $3.3M USD from UNITED STATES across 43 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Trastuzumab sourced from UNITED STATES include ROCHE PRODUCTS (INDIA) PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, ROCHE PRODUCTS I PVT LTD. The largest buyer is ROCHE PRODUCTS (INDIA) PRIVATE LIMITED with $2.2M in imports across 5 shipments.
The total value of Trastuzumab imports from UNITED STATES to India is $3.3M USD, across 43 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
43 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists